NO975636D0 - Farmasöytisk sammensetning for fremming av osteogenese - Google Patents

Farmasöytisk sammensetning for fremming av osteogenese

Info

Publication number
NO975636D0
NO975636D0 NO975636A NO975636A NO975636D0 NO 975636 D0 NO975636 D0 NO 975636D0 NO 975636 A NO975636 A NO 975636A NO 975636 A NO975636 A NO 975636A NO 975636 D0 NO975636 D0 NO 975636D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
promoting osteogenesis
osteogenesis
promoting
pharmaceutical
Prior art date
Application number
NO975636A
Other languages
English (en)
Other versions
NO975636L (no
Inventor
Tetsuo Hoshino
Hiroya Muranishi
Shigehisa Taketomi
Susumi Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO975636D0 publication Critical patent/NO975636D0/no
Publication of NO975636L publication Critical patent/NO975636L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO975636A 1995-06-05 1997-12-04 Farmasöytisk sammensetning for fremming av osteogenese NO975636L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13803695 1995-06-05
JP1168696 1996-01-26
PCT/JP1996/001506 WO1996039134A1 (en) 1995-06-05 1996-06-04 Osteogenetic promoting pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO975636D0 true NO975636D0 (no) 1997-12-04
NO975636L NO975636L (no) 1998-01-28

Family

ID=26347166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975636A NO975636L (no) 1995-06-05 1997-12-04 Farmasöytisk sammensetning for fremming av osteogenese

Country Status (11)

Country Link
EP (1) EP0831808A1 (no)
KR (1) KR19990022514A (no)
AR (1) AR003001A1 (no)
AU (1) AU717260B2 (no)
CA (1) CA2221784A1 (no)
HU (1) HUP9802573A3 (no)
NO (1) NO975636L (no)
NZ (1) NZ308658A (no)
RU (1) RU2188011C2 (no)
TW (1) TW420608B (no)
WO (1) WO1996039134A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264131A1 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance
WO1999065474A2 (en) * 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
EP1103552A4 (en) 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
EP1105140A2 (en) * 1998-08-12 2001-06-13 Takeda Chemical Industries, Ltd. Benzothiepine compounds as enhancer of cell differentiation induction factor
WO2001089521A1 (fr) * 2000-05-23 2001-11-29 Takeda Chemical Industries, Ltd. Compositions medicinales contenant des derives du tiophene
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
WO2004077948A1 (ja) * 2002-12-19 2004-09-16 Nippon Soda Co., Ltd. Oil/Water液中乾燥法による農薬マイクロカプセル製剤及びその製造方法
JP5960593B2 (ja) 2009-04-27 2016-08-02 プレミア デンタル プロダクツ カンパニー マイクロカプセル化組成物及び組織石灰化の方法
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
TWI458503B (zh) * 2013-04-22 2014-11-01 Medical & Pharm Ind Tech & Dev 維生素k微球、其製造方法、用途、及藥劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203020T1 (de) * 1990-05-30 2001-07-15 Takeda Chemical Industries Ltd Schwefel enthaltende heterocyclische verbindungen
US5716944A (en) * 1994-07-04 1998-02-10 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use

Also Published As

Publication number Publication date
HUP9802573A3 (en) 2000-04-28
AU5845796A (en) 1996-12-24
AR003001A1 (es) 1998-05-27
NZ308658A (en) 1999-10-28
KR19990022514A (ko) 1999-03-25
HUP9802573A2 (hu) 1999-09-28
WO1996039134A1 (en) 1996-12-12
EP0831808A1 (en) 1998-04-01
RU2188011C2 (ru) 2002-08-27
TW420608B (en) 2001-02-01
AU717260B2 (en) 2000-03-23
CA2221784A1 (en) 1996-12-12
NO975636L (no) 1998-01-28

Similar Documents

Publication Publication Date Title
NO20004345D0 (no) Farmasøytisk sammensetning
FI973518A (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
IS4706A (is) Lyfjasamsetningar
ID16038A (id) Komposisi farmasi untuk imunomodulasi
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID18352A (id) Komposisi-komposisi farmasi
BR9610214A (pt) Compostos farmacéuticos
NO975636D0 (no) Farmasöytisk sammensetning for fremming av osteogenese
LV11727A (lv) Farmaceitiska kompozicija
EE03857B1 (et) Ravimkoostised külmkuivatamiseks
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
BR9507768A (pt) Composição farmacêutica
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
ID18698A (id) Komposisi farmasi
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
BR9711981A (pt) Produto farmac-utico cristalino
ITMI962628A0 (it) Composizione farmaceutica
NO965448L (no) Farmasöytiske forbindelser
BR9605777A (pt) Composição farmacêutica
DE69632176D1 (de) Anti-inflammatorische Verbindungen
FI962738A (fi) Farmaseuttiset koostumukset
BR9605131A (pt) Composição farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application